Bookkeeping

Rogers Communications Reports Fourth Quarter 2023 Results; Announces 2024 Financial Guidance

Retrieved on: 
Thursday, February 1, 2024

These are not standardized financial measures under International Financial Reporting Standards (IFRS) and might not be comparable to similar financial measures disclosed by other companies.

Key Points: 
  • These are not standardized financial measures under International Financial Reporting Standards (IFRS) and might not be comparable to similar financial measures disclosed by other companies.
  • Consolidated adjusted EBITDA increased 39% this quarter and our adjusted EBITDA margin increased by 340 basis points, as a result of improving synergies and efficiencies.
  • These are not standardized financial measures under IFRS and might not be comparable to similar financial measures disclosed by other companies.
  • The following table outlines guidance ranges that we had previously provided and our actual results and achievements for the selected full-year 2023 financial metrics.

Wabash Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, February 1, 2024

Transportation Solutions’ net sales for the fourth quarter were $547.0 million, a decrease of 10.5% compared to the prior year quarter.

Key Points: 
  • Transportation Solutions’ net sales for the fourth quarter were $547.0 million, a decrease of 10.5% compared to the prior year quarter.
  • During the quarter, operating income was $74.6 million, or 13.6% of sales.
  • Parts & Services' net sales for the fourth quarter were $55.2 million, an increase of 11.2% compared to the prior year quarter.
  • Wabash will discuss its results during its quarterly investor conference call on Thursday, February 1, beginning at 11:00 a.m. EST.

Calavo Growers, Inc. Announces Fourth Quarter and Fiscal 2023 Financial Results

Retrieved on: 
Wednesday, January 31, 2024

SANTA PAULA, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global avocado-industry leader and provider of convenient, ready-to-eat fresh food, today reported its financial results for the fiscal fourth quarter and fiscal year ended October 31, 2023.

Key Points: 
  • SANTA PAULA, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global avocado-industry leader and provider of convenient, ready-to-eat fresh food, today reported its financial results for the fiscal fourth quarter and fiscal year ended October 31, 2023.
  • “Turning to our financial performance, we generated approximately $7.0 million in adjusted EBITDA during the fourth quarter on $241 million of net sales.
  • Gross profit for the fourth quarter was $15.5 million, or 6.4% of net sales, compared to $20.4 million and 8.4%, respectively, for the same period last year.
  • Calavo’s fourth quarter avocado volume declined 8.7% from the prior year as we prioritized margin in our volume management decisions.

SunCoke Energy, Inc. Announces 2023 Results and Provides Full-Year 2024 Guidance

Retrieved on: 
Thursday, February 1, 2024

Our 2024 guidance is as follows:

Key Points: 
  • Our 2024 guidance is as follows:
    We will host our quarterly earnings call at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) today.
  • The conference call will be webcast live and archived for replay in the Investors section of www.suncoke.com.
  • SunCoke Energy, Inc. (NYSE: SXC) supplies high-quality coke to domestic and international customers.
  • Our logistics business provides export and domestic material handling services to coke, coal, steel, power and other bulk customers.

Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust

Retrieved on: 
Thursday, February 1, 2024

Omeros Corporation (Nasdaq: OMER) today announced the sale to DRI Healthcare Acquisitions LP (“DRI”), a wholly owned subsidiary of DRI Healthcare Trust, of an expanded interest in certain royalty payments based on net sales of OMIDRIA in the United States.

Key Points: 
  • Omeros Corporation (Nasdaq: OMER) today announced the sale to DRI Healthcare Acquisitions LP (“DRI”), a wholly owned subsidiary of DRI Healthcare Trust, of an expanded interest in certain royalty payments based on net sales of OMIDRIA in the United States.
  • Under the terms of that asset purchase agreement, Omeros is entitled to receive royalties on net sales of OMIDRIA.
  • Today Omeros and DRI expanded their royalty purchase agreement, resulting in Omeros receiving from DRI an upfront payment of $115 million and entitling DRI to receive the remainder of Omeros’ royalties on U.S. net sales of OMIDRIA payable between January 1, 2024 and December 31, 2031.
  • “We are pleased to have partnered again with DRI, further monetizing our OMIDRIA royalty stream,” said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros.

Carvana, Jimmie Johnson Unveil New Richard Petty-Inspired Paint Scheme Ahead of Daytona 500 Race

Retrieved on: 
Thursday, February 1, 2024

Carvana, an industry pioneer for buying and selling used cars online, today unveiled a new paint scheme for Jimmie Johnson’s No.

Key Points: 
  • Carvana, an industry pioneer for buying and selling used cars online, today unveiled a new paint scheme for Jimmie Johnson’s No.
  • Created in partnership with LEGACY MOTOR CLUB™, the design pays tribute to the Petty family’s illustrious 75-year tenure in racing.
  • View the full release here: https://www.businesswire.com/news/home/20240201156536/en/
    Carvana, an industry pioneer for buying and selling used cars online, today unveiled a new paint scheme for Jimmie Johnson’s No.
  • Access to a first look at the newly outfitted race car is available on NASCAR.com, and on all of Carvana Racing’s social channels.

HubSync Revolutionizes the R&D Tax Credit Process for CPA Firms

Retrieved on: 
Thursday, February 1, 2024

HubSync , a leading CPA firm technology platform, today announced an innovative new Research and Development (R&D) Tax Credit product to streamline the complex process of collecting, organizing, and submitting R&D tax credit data supporting taxpayer claims sent to the IRS for processing.

Key Points: 
  • HubSync , a leading CPA firm technology platform, today announced an innovative new Research and Development (R&D) Tax Credit product to streamline the complex process of collecting, organizing, and submitting R&D tax credit data supporting taxpayer claims sent to the IRS for processing.
  • HubSync developed this new platform in close collaboration with Plante Moran , one of the nation's largest audit, tax, consulting, and wealth management firms and a leader in the R&D Tax Credit market.
  • "We are thrilled to expand the HubSync end-to-end platform to now include a paradigm-shifting CPA firm and client experience for R&D Tax Credits," said John McGowan, Founder and CEO of HubSync.
  • Deliverable Wizard: HubSync's R&D Tax Credit Deliverable Wizard introduces a robust document generator utilized by Plante Moran to build comprehensive IRS R&D tax credit claim submissions for each client.

DISCO Unveils Cecilia Deposition Summaries, an Advanced Tool That Gives Lawyers Fast Analysis of Witness Testimony

Retrieved on: 
Tuesday, January 30, 2024

For lawyers, the process of creating witness deposition summaries is often tedious, time-consuming and costly, and can take focus away from other more strategic tasks.

Key Points: 
  • For lawyers, the process of creating witness deposition summaries is often tedious, time-consuming and costly, and can take focus away from other more strategic tasks.
  • Depo Summaries is a solution that leverages generative AI to give lawyers the ability quickly to make sense of important deposition transcriptions and provide client-ready summaries.
  • These summaries are automatically produced both chronologically and by key topic, and then linked to relevant deposition testimony.
  • Depo Summaries lets legal professionals understand testimony faster and eliminates the need for associates to produce secondary summaries from scratch.

springbig announces issuance of $6.4 million of Convertible Notes due 2026 and $1.6 million Term Loan due 2026 and repurchase of existing Convertible Notes

Retrieved on: 
Wednesday, January 24, 2024

Proceeds from the Convertible Note and Term Loan will be used to repurchase entirely the outstanding existing Senior Secured Convertible Note due 2025 (the “Existing Note”) for a discounted amount of approximately $2.9 million and for general corporate purposes.

Key Points: 
  • Proceeds from the Convertible Note and Term Loan will be used to repurchase entirely the outstanding existing Senior Secured Convertible Note due 2025 (the “Existing Note”) for a discounted amount of approximately $2.9 million and for general corporate purposes.
  • The net proceeds after repurchasing the Existing Note and transaction costs is estimated to be $4.6 million.
  • With the closing of the Convertible Note and Term Loan financing we now have a stronger balance sheet and the capital to support our future growth.
  • The Term Loan will rank pari passu with the Convertible Note and will also mature in January 2026.

Dorchester Minerals, L.P. Announces Its Fourth Quarter Distribution

Retrieved on: 
Thursday, January 18, 2024

DALLAS, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (NASDAQ:DMLP) announced today the Partnership’s fourth quarter 2023 cash distribution.

Key Points: 
  • DALLAS, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (NASDAQ:DMLP) announced today the Partnership’s fourth quarter 2023 cash distribution.
  • Cash receipts attributable to the Partnership’s Royalty Properties during the fourth quarter totaled approximately $28.3 million.
  • Cash Receipts attributable to the Partnership’s Net Profits Interests during the fourth quarter totaled approximately $4.6 million.
  • Cash receipts attributable to lease bonus and other income during the fourth quarter totaled approximately $12.4 million.